04 Jan Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Posted at 10:56h
in Press Releases
- JIM O'MARA NAMED CHIEF EXECUTIVE OFFICER - BOSTON, Jan. 4, 2018 /PRNewswire/ -- Neurogastrx, Inc., a private biopharmaceutical company focused on discovering and developing therapies for gastrointestinal disorders affecting the enteric nervous system, today announced a transformative $45M Series A financing co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. The funds will...
